Early administration of ultraviolet treatment is effective in pegylated interferon alpha-induced severe acute exacerbation of psoriasis: A case report and short review of the literature

International Journal of Clinical Practice

Volumn 64, Issue 1, 2010, Pages 101-103

  Tekin, N S ^a   Ustundag, Y ^a   Tekin, I O ^a   Koca, R ^a   Altinyazar, H C ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; PEGINTERFERON; STEROID;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; DISEASE EXACERBATION; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY; ULTRAVIOLET B RADIATION;

ADULT; ANTIVIRAL AGENTS; HEPATITIS B, CHRONIC; HEPATITIS D; HUMANS; INTERFERON ALFA-2A; MALE; POLYETHYLENE GLYCOLS; PSORIASIS; ULTRAVIOLET THERAPY;

EID: 72449184587     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01040.x     Document Type: Article

References (18)

1. Monkarsh SP, Ma Y, Aglione A et al. Positional isomers of monopegylated interferon alpha-2a: isolation, characterization, and biological activity. Anal Biochem 1997 247 : 434 440.
2. Stafford-Fox V, Guindon KM. Cutaneous reactions associated with alpha interferon therapy. Clin J Oncol Nurs 2000 4 : 164 168.
3. Hui AY, Chan HL, Cheung AY, Cooksley G, Sung JJ. Systematic review: treatment of chronic hepatitis B virus infection by pegylated interferon. Aliment Pharmacol Ther 2005 15 519 528.
4. Chow S, Rizzo C, Ravitskiy L, Sinha AA. The role of T cells in cutaneous autoimmune disease. Autoimmunity 2005 38 : 303 317.
5. Downs AM, Dunnill MG. Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C. Clin Exp Dermatol 2000 25 : 351 352.
6. Funk J, Langeland T, Schrumpf E, Hanssen LE. Psoriasis induced by interferon-α. Br J Dermatol 1991 125 : 463 465.
7. Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology 1992 102 : 2155 2160.
8. Papo T, Marcellin P, Bernuau J, Durand F, Poynard T, Benhamou JP. Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med 1992 116 : 51 3.
9. Hoffnagle J. Thrombocytopenia during interferon alfa therapy. JAMA 1991 266 : 849.
10. Meller S, Erhardt A, Auci A, Neumann NJ, Homey B. Drug-induced exanthema caused by pegylated interferon-alpha 2b. Hautarzt 2003 54 : 992 993.
11. Bessis D, Charron A, Rouzier-Panis R, Blatiere V, Guilhou JJ, Reynes J. Necrotizing cutaneous lesions complicating treatment with pegylated-interferon alfa in an HIV-infected patient. Eur J Dermatol 2002 12 : 99 102.
12. Heinzerling L, Dummer R, Wildberger H, Burg G. Cutaneous ulceration after injection of polyethylene-glycol-modified interferon alpha associated with visual disturbances in a melanoma patient. Dermatology 2000 201 : 154 157.
13. Hurst EA, Mauro T. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature. Arch Dermatol 2005 141 : 865 868.
14. Georgetson MJ, Yarze JC, Lalos AT, Webster GF, Martin P. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis. Am J Gastroenterol 1993 88 : 1756 1758.
15. Wolf R, Ruocco V. Triggered psoriasis. Adv Exp Med Biol 1999 455 : 221 225.
16. Kartal ED, Colak H, Ozgunes I, Usluer G. Exacerbation of psoriasis due to peginterferon alpha-2b plus ribavirin treatment of chronic active hepatitis. Chemotherapy 2005 51 : 167 169.
17. Ketikoglou I, Karatapanis S, Elefsiniotis I, Kafiri G, Moulakakis A. Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B. Eur J Dermatol 2005 15 : 107 109.
18. Neumann R, Pohl-Markel H, Aberer E. Parenteral interferon alpha treatment of psoriasis. Dermatologica 1987 175 : 23 8.